Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Cohort 1: Study of people with multiple early-stage lung cancers (multi-omics study)
Who might be able to join this trial:
- You are between 18 and 75 years old (male or female)
- You are generally healthy and able to carry out normal daily activities with little or no limitation (confirm with trial site)
- Your lung cancer has been confirmed by laboratory testing and is at an early stage (Stage I or II)
- Your doctors have identified you as having multiple or a single primary lung cancer based on established medical guidelines (confirm with trial site)
- You and your family are willing and able to attend follow-up appointments and check-ins over time
- You are willing to read and sign a consent form agreeing to take part in the study
Who may not be able to join:
- You have had, or currently have, any other type of cancer
- You have already received cancer treatments such as chemotherapy, radiation therapy, or targeted drug therapies before joining the study
- You do not wish to take part in the study
Cohort 2: Study of lung cancer associated with air-filled spaces (cystic airspaces)
Who might be able to join this trial:
- You are between 18 and 75 years old (male or female)
- You are generally healthy and able to carry out normal daily activities with little or no limitation (confirm with trial site)
- Your lung cancer has been confirmed by laboratory testing and is at an early stage (Stage I or II)
- Your CT scan shows one or more lung nodules that contain air-filled (cystic) spaces
Who may not be able to join:
- You have had, or currently have, any other type of cancer
- You have already received cancer treatments such as chemotherapy, radiation therapy, or targeted drug therapies before joining the study
- You do not wish to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8673185295188
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Immune repertoire sequencing; DNA methylome sequencing; RNA sequencing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.